Selon une étude présentée lors du congrès de la Société européenne d’oncologie médicale, l'ajout d'une hormonothérapie de ...

The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. In fact, more than 3.5 million men in the United States who have been diagnosed with prostate ...

An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis ...

A new test can identify men who are more at risk of dying from prostate cancer and allow for more personalised treatment.

An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis ...

Hausse de 3 % par an des cancers de la prostate : ce que signifient ces chiffres et comment le dépistage précoce peut limiter ...

Five-year results presented at ASTRO 2026 show a five-week radiation schedule after prostatectomy controls cancer as well as a seven-week course. But serious urinary side effects were more common.

Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule ...

A shorter course of radiotherapy (RT) after prostatectomy provides similar disease control and patient-reported outcomes as conventional fractionation at 5 years — but with a higher rate of ...

SAN ANTONIO — Every September is prostate cancer awareness month. It is a month set aside to bring awareness to the disease that is the most common cancer diagnosed in men. Unlike many other cancers, ...

Abidjan, 26 oct 2026 (AIP)-Alors que la campagne d’Octobre Rose bat son plein, le cancer du sein demeure largement perçu ...